Guides
A little context makes research easier to read.
New to peptides? Start with the basics. Reading a study? Learn what its design and results can tell you, and what they leave unanswered.
What are peptides?
A plain-English primer on peptide basics and why context matters.
Read guidePeptide safety
Understand known risks, gaps in safety data, and why product identity matters.
Read guideClinical trials explained
How to read trial phases, endpoints, registries, and early results.
Read guideFDA-approved peptide medicines
A guide to product-specific approval rather than broad class claims.
Read guidePeptide research glossary
Plain-English definitions for approval, trial, receptor, and safety terms.
Read guideResearch updates
Elamipretide confirmatory trial appears after accelerated approvalWhy the 4TAZPower trial matters for Forzinity's narrow Barth syndrome approval.FDA approves tirzepatide for obstructive sleep apnea in adults with obesityWhat the Zepbound approval covers, what supported it, and what it does not mean.Retatrutide Phase 3 program reports top-line resultsWhat company-reported Phase 3 results do and do not mean while retatrutide remains investigational.